Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRAPP: Procalcitonin to Reduce Antibiotic Use in Pediatric Pneumonia
NCT04963764Phase 1Completed
- Sponsor
- Ann & Robert H Lurie Children's Hospital of Chicago
- Start
- Oct 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in community acquired pneumonia (CAP) comparing Placebo with Amoxicillin (2 arms). Primary endpoint: Total Pilot Trial Enrollment at Day 7. Started Oct 2021; status: completed.
02
Drugs
amoxicillin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT04963764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04963764.